AC Immune(ACIU) - 2022 Q3 - Quarterly Report

Exhibit 99.1 SHAREHOLDERS' EQUITY AND LIABILITIES Shareholders' equity Share capital 1,797 1,794 Share premium 431,303 431,251 Treasury shares 12 (124) (124) Currency translation differences 72 — Accumulated losses (242,994) (200,942) Total shareholders' equity 190,054 231,979 Condensed Consolidated Balance Sheets (Unaudited) (in CHF thousands) | --- | --- | --- | --- | |-------------------------------------|-------|----------------------------------|-------------------------------| | Balance Sheets \nASSET ...